Shortlisted for Best ADC CRO Award !

ChemExpress have been shortlisted as Best CRO (Contract Research Organization) at the 11th World ADC Awards. World ADC Event Series is the world’s longest-standing and definitive Antibody-Drug Conjugate conference. We’re so proud to be nominated for this award. It’s all because of our amazing team and the incredible support from our clients and collaborators

  Upcoming Events!

We look forward to seeing you in World ADC San Diego 2024.

ChemExpress’s Capability In ADC

ChemExpress has developed an extensive library of ADC payloads, linkers, and payload-linkers, with over 80 payloads and 400 linkers in stock. Notably, 12 ADC payloads and related intermediates are registered with the FDA DMF, including widely used payloads such as MMAE, Vc-MMAE, Exatecan, Eribulin, and more. Our diverse portfolio provides customers with flexible solutions. Additionally, we have extensive experience in synthesizing over 1,000 linker compounds, enabling us to efficiently produce the most complex linker structures.

Over the past 12 months, ChemExpress has successfully completed more than 110 ADC payload-linker projects, supported clients with 5 projects in preparation for BLA submission. We also expanded our customized ADC conjugation, delivering over 80 ADC conjugate (DS) samples. With more than 10 years of experience and a team of over 230 experts, we have collaborated with more than 800 clients.

Want to learn more about our ADC service?

Please click on this link:

https://www.chemexpress.com/adc_highPotencyAPI

Any questions, please contact us at

info@chemexpress.com

ChemExpress XDC Payload-Linker CMC Integrated Platform

Payloads

Linkers

• DBCO-NHS Ester

• Mc-Val-Ala-PAB-PNP

• Fmoc-Val-Cit-PAB-PNP

• Mc-Val-Cit-PABC-PNP

• Lys(MMT)-PAB-oxydiacetamide-PEG8-N3

• MAC glucuronide linker-2

• Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar

You may also be interested in:

•Exploring Out-Licensing Deals for Innovative ADC Drugs from China

•US FDA Inspection Concludes with Zero Observations

•Genmab buys ProfoundBio for $1.8B, Improving the Hydrophobicity of Exatecan is key

•Big deal! Multitude and Adcendo signed a licensing Agreement for a ADC drug

Shanghai Haoyuan ChemExpress Co., Ltd.

T: (+86) 021-58950125

E: info@chemexpress.com

A: No. 3 Building, No. 1999, Zhangheng Road, Pudong New Area, Shanghai, P.R.China

www.chemexpress.com